Aflac Incorporated : Technically solid
Entry price | Target | Stop-loss | Potential |
---|
$79.71 |
$86 |
$74 |
+7.89% |
---|
The current trading zone is interesting to the point that investors should pay attention to the stock and anticipate a return of the underlying upward trend.
Strengths● The group's activity appears highly profitable thanks to its outperforming net margins.
● The company's attractive earnings multiples are brought to light by a P/E ratio at 9.44 for the current year.
● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
● Over the past four months, analysts' average price target has been revised upwards significantly.
● Considering the small differences between the analysts' various estimates, the group's business visibility is good.
● The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
● The group usually releases upbeat results with huge surprise rates.
Weaknesses● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● The company's earnings growth outlook lacks momentum and is a weakness.
● The average consensus view of analysts covering the stock has deteriorated over the past four months.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.